VYCO
Price
$0.07
Change
-$0.00 (-0.00%)
Updated
Dec 20 closing price
XVIPF
Price
$41.10
Change
-$1.80 (-4.20%)
Updated
Dec 17 closing price
Ad is loading...

VYCO vs XVIPF

Header iconVYCO vs XVIPF Comparison
Open Charts VYCO vs XVIPFBanner chart's image
Vycor Medical
Price$0.07
Change-$0.00 (-0.00%)
Volume$2.08K
CapitalizationN/A
Xvivo Perfusion AB
Price$41.10
Change-$1.80 (-4.20%)
Volume$100
CapitalizationN/A
VYCO vs XVIPF Comparison Chart
Loading...
VYCO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XVIPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
VYCO vs. XVIPF commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is VYCO is a Hold and XVIPF is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (VYCO: $0.07 vs. XVIPF: $41.10)
Brand notoriety: VYCO and XVIPF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: VYCO: 14% vs. XVIPF: 26%
Market capitalization -- VYCO: $3.13M vs. XVIPF: $905.23M
VYCO [@Medical Specialties] is valued at $3.13M. XVIPF’s [@Medical Specialties] market capitalization is $905.23M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.04B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

VYCO’s FA Score shows that 1 FA rating(s) are green whileXVIPF’s FA Score has 0 green FA rating(s).

  • VYCO’s FA Score: 1 green, 4 red.
  • XVIPF’s FA Score: 0 green, 5 red.
According to our system of comparison, XVIPF is a better buy in the long-term than VYCO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

VYCO’s TA Score shows that 3 TA indicator(s) are bullish while XVIPF’s TA Score has 3 bullish TA indicator(s).

  • VYCO’s TA Score: 3 bullish, 6 bearish.
  • XVIPF’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, XVIPF is a better buy in the short-term than VYCO.

Price Growth

VYCO (@Medical Specialties) experienced а +2.19% price change this week, while XVIPF (@Medical Specialties) price change was -4.20% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.51%. For the same industry, the average monthly price growth was +1.92%, and the average quarterly price growth was +0.64%.

Industries' Descriptions

@Medical Specialties (-1.51% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
XVIPF($905M) has a higher market cap than VYCO($3.13M). XVIPF YTD gains are higher at: 80.263 vs. VYCO (-9.456). XVIPF has higher annual earnings (EBITDA): 29.2M vs. VYCO (-159.57K). XVIPF has more cash in the bank: 171M vs. VYCO (47.8K). VYCO has less debt than XVIPF: VYCO (967K) vs XVIPF (27.6M). XVIPF has higher revenues than VYCO: XVIPF (524M) vs VYCO (1.27M).
VYCOXVIPFVYCO / XVIPF
Capitalization3.13M905M0%
EBITDA-159.57K29.2M-1%
Gain YTD-9.45680.263-12%
P/E RatioN/A344.83-
Revenue1.27M524M0%
Total Cash47.8K171M0%
Total Debt967K27.6M4%
FUNDAMENTALS RATINGS
VYCO vs XVIPF: Fundamental Ratings
VYCO
XVIPF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
90
Overvalued
PROFIT vs RISK RATING
1..100
10049
SMR RATING
1..100
10069
PRICE GROWTH RATING
1..100
8648
P/E GROWTH RATING
1..100
10084
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VYCO's Valuation (23) in the null industry is significantly better than the same rating for XVIPF (90). This means that VYCO’s stock grew significantly faster than XVIPF’s over the last 12 months.

XVIPF's Profit vs Risk Rating (49) in the null industry is somewhat better than the same rating for VYCO (100). This means that XVIPF’s stock grew somewhat faster than VYCO’s over the last 12 months.

XVIPF's SMR Rating (69) in the null industry is in the same range as VYCO (100). This means that XVIPF’s stock grew similarly to VYCO’s over the last 12 months.

XVIPF's Price Growth Rating (48) in the null industry is somewhat better than the same rating for VYCO (86). This means that XVIPF’s stock grew somewhat faster than VYCO’s over the last 12 months.

XVIPF's P/E Growth Rating (84) in the null industry is in the same range as VYCO (100). This means that XVIPF’s stock grew similarly to VYCO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
VYCOXVIPF
RSI
ODDS (%)
Bullish Trend 3 days ago
55%
Bullish Trend 3 days ago
44%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
41%
Momentum
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
51%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
45%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
50%
Bearish Trend 3 days ago
56%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
44%
Advances
ODDS (%)
Bullish Trend 7 days ago
77%
N/A
Declines
ODDS (%)
Bearish Trend 11 days ago
85%
N/A
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
56%
Bullish Trend 3 days ago
50%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
52%
View a ticker or compare two or three
Ad is loading...
VYCO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XVIPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
USISX17.610.22
+1.27%
Victory Income Stock
BRUEX15.220.17
+1.13%
MFS Blended Research Value Equity B
KNGYX12.340.11
+0.90%
Vest S&P500 Div Aristocrats Trgt IncY
TRUZX58.290.50
+0.87%
T. Rowe Price New Horizons Z
DILRX15.96-0.04
-0.25%
DFA International Large Cap Growth

VYCO and

Correlation & Price change

A.I.dvisor tells us that VYCO and ZJYL have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VYCO and ZJYL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VYCO
1D Price
Change %
VYCO100%
+1.49%
ZJYL - VYCO
24%
Poorly correlated
+1.19%
RSCF - VYCO
21%
Poorly correlated
-0.88%
XVIPF - VYCO
17%
Poorly correlated
N/A
ZTEK - VYCO
8%
Poorly correlated
-4.44%
OM - VYCO
2%
Poorly correlated
+9.01%
More

XVIPF and

Correlation & Price change

A.I.dvisor tells us that XVIPF and USAQ have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that XVIPF and USAQ's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XVIPF
1D Price
Change %
XVIPF100%
N/A
USAQ - XVIPF
22%
Poorly correlated
+19.05%
NSTM - XVIPF
21%
Poorly correlated
-3.40%
VYCO - XVIPF
17%
Poorly correlated
+1.49%
ZTEK - XVIPF
9%
Poorly correlated
-4.44%
LUNG - XVIPF
6%
Poorly correlated
+3.71%
More